Sheila Weinmann to Uterine Cervical Neoplasms
This is a "connection" page, showing publications Sheila Weinmann has written about Uterine Cervical Neoplasms.
Connection Strength
2.171
-
Pregnancy Outcomes after Treatment for Cervical Cancer Precursor Lesions: An Observational Study. PLoS One. 2017; 12(1):e0165276.
Score: 0.479
-
Cervical cancer screening and follow-up in 4 geographically diverse US health care systems, 1998 through 2007. Cancer. 2015 Sep 01; 121(17):2976-83.
Score: 0.428
-
Implementation of systems strategies for breast and cervical cancer screening services in health maintenance organizations. Am J Manag Care. 2003 Nov; 9(11):745-55.
Score: 0.192
-
Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017. J Low Genit Tract Dis. 2022 Apr 01; 26(2):135-139.
Score: 0.172
-
Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination. Vaccine. 2019 06 27; 37(29):3918-3924.
Score: 0.141
-
Pregnancy after treatment for cervical cancer precursor lesions in a retrospective matched cohort. PLoS One. 2015; 10(2):e0117525.
Score: 0.105
-
Follow-up and clinical significance of unsatisfactory liquid-based Papanicolaou tests. Cancer Cytopathol. 2015 Jan; 123(1):59-65.
Score: 0.103
-
Cervical screening and cervical cancer death among older women: a population-based, case-control study. Am J Epidemiol. 2014 May 01; 179(9):1107-14.
Score: 0.099
-
Efficacy of screening in preventing cervical cancer among older women. Cancer Causes Control. 2013 Sep; 24(9):1653-60.
Score: 0.093
-
Effects of transitioning from conventional methods to liquid-based methods on unsatisfactory Papanicolaou tests: results from a multicenter US study. Cancer Cytopathol. 2013 Oct; 121(10):568-75.
Score: 0.093
-
Cervical intraepithelial neoplasia grade 3 and adenocarcinoma in situ: comparison of ICD-9 codes and pathology results--Kaiser Permanente, United States, 2000-2005. Cancer Epidemiol Biomarkers Prev. 2013 Jun; 22(6):1129-32.
Score: 0.092
-
Prevalence of HPV types in cervical specimens from an integrated healthcare delivery system: baseline assessment to measure HPV vaccine impact. Cancer Causes Control. 2013 Feb; 24(2):403-7.
Score: 0.091
-
Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. J Natl Cancer Inst. 2005 May 04; 97(9):675-83.
Score: 0.053
-
Harms of cervical cancer screening in the United States and the Netherlands. Int J Cancer. 2017 Mar 01; 140(5):1215-1222.
Score: 0.030